Report
Should GLP-1 drugs be used to treat obesity in children as young as 8?
New Scientist reports a study found 9.3 percent of US children ages 8 to 11 with obesity but without diabetes were prescribed GLP-1 drugs.
TLDR
New Scientist reports that children as young as 8 in the US are being prescribed off-label GLP-1 weight-loss drugs. It cites a study finding that 9.3 percent of US children ages 8 to 11 with obesity but without diabetes were prescribed the drugs, up from 0.03 percent in 2019. The article says there are signs the drugs treat obesity in these children, alongside concerns about long-term effects.
Combined views
2.4K
1 Source, first seen ago
1 reposts
